CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
CapsoVision received FDA clearance for AI Highlights, an AI-assisted reading tool for its CapsoCam Plus capsule endoscopy system, cleared September 25, 2026. The tool flags suspected abnormal lesions to reduce physician review time and integrates with CapsoView and CapsoCloud workflows; it follows an earlier international launch including the EU under MDR.
Key figures
- Drug Name
- AI Highlights
- Clearance date
- 2026-09-25
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.